Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
genentech
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
4d molecular therapeutics
abbvie
acetylon pharmaceuticals
acne
agenus
ambys medicines
astrazeneca
auris health
avexis
bayer
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
cell therapy
centers for medicare and medicaid services
clinical trials
constellation pharmaceuticals
What
liver
2
×
aiming
ambys
approved
big
bio
biotech
companies
control
deadly
deal
debuted
digital
disease
diseases
drug
epidemic
fatty
fda
formed
frenzied
future
growing
known
launch
led
make
medicines
merck
nash
new
news
race
roundup
startup
strikes
takeda
today
tokens
treatment
Language
Current search:
genentech
×
liver
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
